Genes2Me Pvt Ltd, Gurugram, has announced the release of its Rapi-Q point-of-care RT PCR solution for 1-8 samples, which is simple to use and produces results in less than 45 minutes. This CE-IVD marked POC solution provides superior performance, high sensitivity, and stable detection thanks to a powerful software analysis function.
What is Rapi-Q
Rapi-Q point of contact The ICMR has approved RT PCR after stringent quality checks. This compact, lightweight, and portable system can process up to eight samples in a single run. Rapi-Q is ideal for detecting tuberculosis (TB), HPV, 3H (HIV, HCV, and HBV), tropical fever, and respiratory ailments.
Neeraj Gupta, CEO, Genes2Me said, “The test provides much faster access to accurate test results for several diseases at once, allowing for more rapid clinical decision-making and more-appropriate treatments and interventions. In addition, Rapi-Q can help minimise time-dependent changes in samples which can be caused due to delays in the transport of samples to the clinical laboratory. Also, since it tests up to eight samples at once and has a long service life, the test is energy-efficient and environmentally friendly.”
Rapi-Q is made up of an eight-well block with four fluorescent channels. It can perform singleplex and multiplex analyses for qualitative and quantitative data, melting curve analysis, genotyping, and so on. Because it is lightweight (less than 3 kg), it can be easily installed in mass testing facilities. In detecting various diseases, the test has high sensitivity, accuracy, and performance. It also works with more than 50 lyophilized room temperature stable disease detection kits. This system automates analysis, interpretation, and reporting.
